Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
admin The approval of Regeneron’s Pasatru (garetosmab) represents the culmination of a thirty-year scientific odyssey. For...
Health
Morning Rounds: ACS Severs Alcohol Ties, FDA Leadership Shifts, and the Evolution of Brain Organoids.
The landscape of modern oncology is shifting rapidly, marked not only by breakthroughs in biotechnology...
The New Era of Biotechnology: Merck and Moderna’s Cancer Vaccine Breakthrough and the Five-Year Evolution of Harvard’s Brain Organoids.
The landscape of modern medicine is currently witnessing a tectonic shift, driven by the convergence...
The Trump Administration’s Nomination of Heidi Overton as FDA Commissioner Marks a Pivotal Shift in Federal Health Policy.
The selection of Dr. Heidi Overton to lead the Food and Drug Administration (FDA) serves...
The Rise of Focal Therapy: A Disruptive Middle Ground in the Evolution of Prostate Cancer Care
For decades, the management of localized prostate cancer has been defined by a stark, binary...
The Myth of the Tortured Genius: Why High Achievers Fear Mental Health Treatment.
When the global superstar Lil Nas X recently disclosed his diagnosis of bipolar disorder, the...
The Looming Benefits Cliff: Why an HIV Cure Must Not Come at the Cost of Survival for Long-Term Patients.
For more than four decades, the global scientific community has chased the "holy grail" of...
Scientists deploy Merck’s Ebola vaccine in DRC
The resurgence of smart eyewear, specifically Meta’s AI-powered Ray-Bans, marks a significant departure from the...
Are cancer patients getting too much drug?
The saga of Moderna serves as a primary case study for the post-pandemic biotech economy....
Trump’s FDA Nominee Faces Uphill Battle Amidst Growing Concerns Over Estrogen Patch Shortages and Regulatory Shifts.
As the summer of 2026 enters its final weeks, the intersection of high-stakes federal politics...
